EntoZyme

Private

SydneyHealthcare & Life Scienceshttps://www.entozyme.com/

Last Round

Seed

Oct 26, 2023

Total Funding Raised

$320,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EntoZyme is a biotechnology company that develops genetic engineering techniques to process various organic waste streams and produce valuable enzymes and bioactive compounds.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Circular Economy, Sustainable Materials, Waste Management

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

synthetic biologygenetic engineeringBlack Soldier FliesBSFwaste-to-valuesynbiobiomanufacturing platforminsect proteinalternative proteinsorganic waste conversionaquaculture feedanimal feed ingredientscircular economyupcycled ingredientsindustrial enzymesinsect farmingsustainable aviation fueldeep tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EntoZyme Comps

Public and private peers based on sector, stage, and business model.

EntoZyme comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EntoZyme Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Oct 26, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Maciej Maselko

Co-Founder and CEO

Founding Team

EntoZyme Investors

Notable investors and investment history

EntoZyme investors
Investor	Rounds
Macquarie University Incubator	Seed
UNSW Founders	Seed
Main Sequence Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 2, 2026
Monthly visitors increased 145% MoM.

View all signals

EntoZyme Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

EntoZyme Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EntoZyme's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney

Employee Range8

Year Founded2024

Last FundingOct 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.